8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...

8/19/2025Six Key Insights Into China Biotech's NewCo Model (Mondaq)

8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 

8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...

8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...

8/19/2025Aeonvital Biomedical Advances Personalized Cancer Therapies with New F...

8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...

8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025

8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval

8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success

8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China

8/18/2025Tarlatamab Shows Promising Results in Chinese Phase 2 Trial for Heavil...

8/18/2025Latticon Completes Series A Financing to Advance Trial of LAT010 Immun...

8/18/2025Aoda Raises CNY30M Series A to Advance Dual-Receptor Agonist Program

8/18/2025Yixuan Secures Angel Financing to Advance Novel Nucleic Acid Drug Deve...

8/18/2025Pleryon Completes First Closing of Series A Financing

8/15/2025Guangzhou Innogen Pharma Debuts on HKSE Amid Expanding Metabolic Pipel...

8/15/2025NHSA Issues Interim Measures for Disease-Based Medical Insurance Payme...

8/14/2025ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by W...

8/14/2025Amphastar Strikes Major Licensing Deal to Supercharge Peptide Pipeline

8/14/2025Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of Oral GLP-1 Ago...

8/14/2025Qihan Earns FDA Green Light for Pioneering Dual-Target CAR-T Therapy i...

8/14/2025GenFleet's GFH375 KRAS G12D Inhibitor Delivers Strong NSCLC Data

8/14/2025YolTech Unveils Breakthru In Vivo Editing of Human Blood Stem Cells

8/14/2025CTTQ Unveils Promising Phase 2 Data for HER2 Bispecific ADC TQB2102

8/14/2025Remegen's Telitacicept Achieves Phase III Success

8/14/2025CDE Seeks Public Input on Draft Guidelines for Rare Disease Drug Devel...

8/14/2025CDE Solicits Comments on Draft ICH M4Q(R2) Guidelines for Drug Qualit...

8/14/2025CDE Issues New Technical Guidelines for Clinical Development of Osteoa...

8/14/2025CDE Seeks Public Input on Draft Guidelines for Bayesian Methods in Cli...

Page:2/786 Total number of articles:23552: [First][<<] [1] [2] [3] [4] [5] [>>] [End]